C M Bidwell & Associates LTD Abbott Laboratories Transaction History

C M Bidwell & Associates LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$100.78 - $112.29 $98,562 - $109,819	978 New	978 $106,000
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $74,511 - $90,060	-730 Closed	0 $0
Q1 2022 Apr 29, 2022	BUY	$114.02 - $139.04 $83,234 - $101,499	730 New	730 $86,000
Q1 2021 May 14, 2021	SELL	$108.84 - $128.23 $215,612 - $254,023	-1,981 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $4,830 - $5,263	-46 Reduced 2.27%	1,981 $217,000
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $89,898 - $109,175	-981 Reduced 32.61%	2,027 $221,000
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $230,322 - $294,784	3,008 New	3,008 $275,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

Stay updated on C M Bidwell & Associates LTD with notifications on news.